Empagliflozin and Finerenone: Hyperkalemia Risk in CKD

Early SGLT2i/MRA Use Benefits Suspected HF Patients

Pelacarsen Cuts Lipoprotein Apheresis Need in CVD

Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia

TAVR vs Surgery: No Difference at 7 Years in Low-Risk AS

Plaque Burden on CCTA Predicts MACE in Early CAD

Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2

NOAC Monotherapy Noninferior to Combo Therapy Post-DES

Low-Dose Triple Pill vs Monotherapy for Hypertension

Acoramidis Reduces Cumulative CV Events in ATTR-CM